Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study
Luke Howard, J.F. Kingrey, David Mottola, Ed Parsley et al.
Citations
1 citations
Journal
Advances in Therapy
Topics
Pulmonary Hypertension Research and Treatments
Field-Weighted Citation Impact (FWCI)
1.52
article
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study
Luke Howard, J.F. Kingrey, David Mottola, Ed Parsley, Robert F. Roscigno, Lawrence S. Zisman, Roham T. Zamanian, Anna ter Veer, Anna R. Hemnes, Vallerie V. McLaughlin, Irina Sobol, Sandeep Sahay, Richard N. Channick, Pilar Escribano Subías, Kelly Chin, Robert P. Frantz, Raymond L. Benza, Namita Sood, Ronald Zolty, Hossein Ardeschir Ghofrani, Olivier Sitbon, John J. Ryan, Richard Aranda
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 42(10)
Institutions
Universidad Complutense de Madrid (ES), Université Libre de Bruxelles (BE), Imperial College Healthcare NHS Trust (GB), Vanderbilt University (US), Cornell University (US), University of Utah (US), Université Paris-Saclay (FR), University of Michigan (US), UCLA Medical Center (US), Hammersmith Hospital (GB), Research Institute Hospital 12 de Octubre (ES), Presbyterian Hospital (US), Southwestern Medical Center (US), Methodist Hospital (US), Gossamer Bio (United States) (US), Mayo Clinic in Arizona (US), Universities of Giessen and Marburg Lung Center (DE), Cardio-Pulmonary Institute (DE), Integris Health (US), University of California Davis Medical Center (US), Bicêtre Hospital (FR), Southwestern Medical Center (US), Imperial College London (GB), University of Nebraska Medical Center (US), The University of Texas Southwestern Medical Center (US), Stanford University (US), Icahn School of Medicine at Mount Sinai (US)